Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
From Lab to Scale: A Game-Changing Approach to Peptide Purification in GLP-1 Manufacturing In the rapidly evolving landscape of peptide therapeutics, particularly with the surge in GLP-1 receptor agonists, manufacturing efficiency has become a critical differentiator
Novo Nordisk, Pfizer and other big pharma companies have just taken [the hormone] GLP-1 itself, and spent 20 years stabilising the peptide, making it druggable, so its not broken down [in the body], explains John Unitt, vice president of immunology and inflammation drug discovery at Sygnature Discovery in Nottinghamshire, UK, and a GPCR drug discovery expert
The buzz around these medicines has a lot of patients asking for more information about GLP-1s
Conclusion: Using our novel ddPCR assay for circulating mtDNA we show for the first time that proinflammatory and pro-fibrogenic mtDNA is released during active AH and correlates with parameters of alcohol-related liver injury and abnormal lipid metabolism
For semaglutide-specific strategies, our constipation treatment guide covers evidence-based interventions
Clin Invest
US$ 25.69
US$ 22.16
US$ 20.07
US$ 23.09
US$ 23.07
US$ 20.46
US$ 24.20
